1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Suicidal: new trials by email Literature Review of Suicidal trials Research Report on Suicidal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth SAFETY-A within usual ED Care, Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts - Suicide, Suicidal | Phase 2 | Recruiting | University of California, Los Angeles | 1600 | 2022-10-17 | 2025-12-31 |
| A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide SLS-002, Placebo, Standard of care - Depressive Disorder, Major, Suicidal | Phase 2 | Completed | Seelos Therapeutics, Inc. | 164 | 2020-12-17 | 2023-09-28 |
Self-Injurious Behavior (2) · Suicide (2) · Behavioral Symptoms (1) · Depression (1) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Mental Disorders (1) · Mood Disorders (1) · Suicidal Ideation (1)
Behavior (2) · Behavioral Symptoms (1)
Ketamine (1) · Standard of Care (1)
Seelos Therapeutics, Inc. (1) · University of California, Los Angeles (1)
United States (2)
David Goldston, PhD (1) · Joan R Asarnow, PhD (1)